0

Maria Glushkova

Rostov State Medical University; DAVINCI Clinical Diagnostic Center, Russian Federation

Presentation Title:

Systemic blood changes in skin hyperpigmentation: Correction possibilities

Abstract

Acquired hyperpigmentation is widespread in the population and significantly affects the quality of life of the patients. It is known that one of the clinical signs of skin hyperpigmentation is localized hyperkeratosis in the lesion associated with a high level of cell proliferation and cell saturation with melanin. Cellular proliferation and hyperkeratosis are associated with increased local metabolism rates.The phenomenon of skin hyperpigmentation is accompanied by a restructuring of blood cell metabolism aimed at preserving oxygen and energy homeostasis of skin structures. The obtained data indicate redistribution of oxygen in cellular structures and tissues, which is accompanied by a significant increase in lactate concentration and formation of local tissue hypoxia.

Biography

She is the Assistant Professor at Rostov State Medical University, Scientific Director of the Department of Medical Cosmetology at the DAVINCI Clinical Diagnostic Center, Rostov-on-Don, Russia. Dermatologist, aesthetic doctor. She has over 4 publications. Graduated from the Medical Faculty of Irkutsk State Medical University 2006-2012. Additionally, she was awarded the specialty of a referent translator of scientific medical literature (French) at the Department of Foreign Languages of IGMU from 06/22/2012. Internship at the hospital in Grenoble, France, 2011.
Internship in Dermatovenerology 2012-2013 on the basis of Rostov State Medical University.Advanced training in laser medicine of the Federal State Budgetary Educational Institution "State Scientific Center of Laser Medicine of the Federal Medical and Biological Agency", Moscow, in the specialty Dermatovenerology and Cosmetology.Certificate of advanced training under the program "Diagnosis and treatment of precancerous and tumor diseases of the skin and subcutaneous tissue" in the Rostov Scientific Research Oncological Institute of the Ministry of Health of the Russian Federation.